Pembrolizumab for the treatment of disease relapse after allogeneic hematopoietic stem cell transplantation.
Godfrey J, Liu H, Yu J, Tallarico M, Curran E, Artz A, Riedell PA, Stock W, Karrison T, Fitzpatrick C, Venkataraman G, Cooper A, Smith SM, Bishop MR, Kline J.
Godfrey J, et al. Among authors: tallarico m.
Blood Adv. 2023 Mar 28;7(6):963-970. doi: 10.1182/bloodadvances.2022008403.
Blood Adv. 2023.
PMID: 35973200
Free PMC article.